Literature DB >> 14723840

Pill Esophagitis.

Nathaniel S. Winstead1, Robert Bulat.   

Abstract

Pill esophagitis is a preventable cause of morbidity. Simple advice on how and when to take medication could probably prevent most cases of the illness. Avoidance of implicated medications in patients with significant risk factors for developing pill esophagitis could prevent additional cases. When the disease presents despite these preventive measures, the mainstays of treatment are immediate discontinuation of the offending agent and supportive care. If the diagnosis is in question, the principle diagnostic modalities are double-contrast barium esophagogram and esophagogastroduodenoscopy. Medical management of moderate to severe cases includes sucralfate to coat, protect, and promote healing of ulcerated esophageal mucosa, and acid-suppressing therapy if gastroesophageal reflux disease is felt to have played a role in the pathogenesis of the illness. Rare cases may require therapeutic endoscopy or surgical intervention early in the disease course. Late complications include esophageal strictures that may require therapeutic endoscopy or bougienage.

Entities:  

Year:  2004        PMID: 14723840     DOI: 10.1007/s11938-004-0027-z

Source DB:  PubMed          Journal:  Curr Treat Options Gastroenterol        ISSN: 1092-8472


  21 in total

1.  Rate of flow of human parotid, sublingual, and submaxillary secretions during sleep.

Authors:  L H SCHNEYER; W PIGMAN; L HANAHAN; R W GILMORE
Journal:  J Dent Res       Date:  1956-02       Impact factor: 6.116

Review 2.  Pill-induced esophageal injury.

Authors:  J W Kikendall
Journal:  Gastroenterol Clin North Am       Date:  1991-12       Impact factor: 3.806

3.  Clinitest ingestion.

Authors:  A Mallory; J W Schaefer
Journal:  Br Med J       Date:  1977-07-09

Review 4.  Drug-induced oesophageal disorders: pathogenesis, incidence, prevention and management.

Authors:  D Jaspersen
Journal:  Drug Saf       Date:  2000-03       Impact factor: 5.606

5.  Oesophageal obstruction and ulceration caused by oral potassium therapy.

Authors:  J Pemberton
Journal:  Br Heart J       Date:  1970-03

6.  An unusual presentation of pill-induced esophagitis.

Authors:  T N Chami; P Nikoomanesh; P O Katz
Journal:  Gastrointest Endosc       Date:  1995-09       Impact factor: 9.427

Review 7.  Esophagitis caused by nonsteroidal anti-inflammatory medication: case reports and review of the literature on pill-induced esophageal injury.

Authors:  A G Coates; T T Nostrant; J A Wilson; G H Elta; F P Agha
Journal:  South Med J       Date:  1986-09       Impact factor: 0.954

8.  Esophageal and small bowel obstruction from guar gum-containing "diet pills": analysis of 26 cases reported to the Food and Drug Administration.

Authors:  J H Lewis
Journal:  Am J Gastroenterol       Date:  1992-10       Impact factor: 10.864

Review 9.  Esophagitis associated with the use of alendronate.

Authors:  P C de Groen; D F Lubbe; L J Hirsch; A Daifotis; W Stephenson; D Freedholm; S Pryor-Tillotson; M J Seleznick; H Pinkas; K K Wang
Journal:  N Engl J Med       Date:  1996-10-03       Impact factor: 91.245

10.  Physiological and morphological effects of alendronate on rabbit esophageal epithelium.

Authors:  A Dobrucali; N A Tobey; M S Awayda; C Argote; S Abdulnour-Nakhoul; W Shao; R C Orlando
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2002-09       Impact factor: 4.052

View more
  1 in total

1.  Exposure to non-steroid anti-inflammatory drugs (NSAIDs) and suppressing hydrogen sulfide synthesis leads to altered structure and impaired function of the oesophagus and oesophagogastric junction.

Authors:  Oksana Zayachkivska; Nazar Bula; Dzvinka Khyrivska; Elena Gavrilyuk; John L Wallace
Journal:  Inflammopharmacology       Date:  2015-02-25       Impact factor: 4.473

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.